IP Library Granted Patent US 6,962,775
Granted Patent B2
US 6,962,775 · App. 10/176,212 · Granted Nov 8, 2005

Wound repair dressings and methods for their preservation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,962,775
App. No.
10/176,212
Granted
Nov 8, 2005
Kind
B2
Abstract

Methods and products relating the preservation of cultured mammalian epithelial or mesenchymal cells are provided. The methods involve the pre-treatment of epithelial cells with a solution containing a cryoprotectant amount of monosaccharides and/or disaccharides. The treated cells then are frozen, dried or freeze-dried in a minimum volume of solution and stored for later use. The invention avoids the use of materials that must be washed away from the preserved tissue prior to application of the tissue to a wound bed. The invention also permits the storage of epithelial tissue in a dry state.

Claims (14)

1. A method for preserving cultured mammalian epithelial or mesenchymal cells, comprising:

incubating the cells in a cryopreservant solution,

removing excess cryopreservant solution from the cells to form a minimum volume of solution in contact with the cells, wherein said minimum volume is not more than 30 ml solution per 50 cm 2 graft of cultured mammalian epithelial or mesenchymal cells, and

freezing or freeze-drying the cells in contact with the minimum volume of cryoprotectant solution.

2. The method of claim 1 wherein the excess cryopreservant solution is removed by draining.

3. The method of claim 1 wherein the excess cryopreservant solution is removed by aspiration.

4. The method of claim 1 wherein the cells in contact with the minimum volume are frozen.

5. The method of claim 1 wherein the cells in contact with the minimum volume are freeze-dried.

6. The method of claim 1 wherein the cryoprotectant solution contains a cryoprotectant amount of a monosaccharide.

7. The method of claim 1 wherein the cryoprotectant solution contains a cryoprotectant amount of a disaccharide.

8. The method of claim 1 wherein the cryoprotectant solution contains a cryoprotectant amount of glucose.

9. The method of claim 1 wherein the cryoprotectant amount of glucose is between 0.05 and 3.5 M glucose.

10. The method of claim 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 or 9 wherein the cells are a sheet of cultured epithelial cells.

11. The method of claim 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 or 9 wherein the cells are cultured on a substratum.

Assignments (7)
CHANGE OF NAME Recorded Apr 2, 2013
From: ADVANCED BIOHEALING, INC.
To: SHIRE REGENERATIVE MEDICINE, INC.
Reel/Frame 030130/0385 →
RELEASE OF SECURITY Recorded Jun 25, 2007
From: ADVANCED BIOHEALING, INC.
To: CANAAN VII L.P., AS ADMINISTRATION AGENT
Reel/Frame 019489/0951 →
RELEASE OF SECURITY INTEREST Recorded Mar 22, 2007
From: HORIZON TECHNOLOGY FUNDING COMPANY LLC
To: ADVANCED BIOHEALING, INC.
Reel/Frame 019193/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2007
From: KURI-HARCUCH, WALID; CASTRO-MUNOZLEDO, FEDERICO; SALAZAR-OLIVO, LUIS; DEKURI, MEYTHA MARSH
To: ADVANCED BIOHEALING, INC.
Reel/Frame 018942/0001 →
SECURITY AGREEMENT Recorded Jan 19, 2007
From: ADVANCED BIOHEALING, INC.
To: HORIZON TECHNOLOGY FUNDING COMPANY LLC
Reel/Frame 018806/0123 →
SECURITY AGREEMENT Recorded Sep 15, 2006
From: ADVANCED BIOHEALING, INC.
To: CANAAN VII L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 018313/0385 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2004
From: CELANDON SCIENCE, LLC
To: ADVANCED BIOHEALING, INC.
Reel/Frame 015108/0973 →